Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Estimated Rate of Retinal Ganglion Cell Loss with Aging
Author Affiliations & Notes
  • Veronica Campos
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Carolina Gracitelli
    Universidade Federal de Sao Paulo Escola Paulista de Medicina, Sao Paulo, SP, Brazil
  • Alessandro A Jammal
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Felipe Medeiros
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Veronica Campos None; Carolina Gracitelli None; Alessandro Jammal None; Felipe Medeiros Abbie,Annexon,Astellas,Carl Zeiss Meditec,Galimedix,, Code C (Consultant/Contractor), ONL Therapeutics,Stealth Biotherapeutics, Stuart Therapeutics, Code C (Consultant/Contractor), Thea Pharmaceuticals, Reichert, Code C (Consultant/Contractor), Perfusion Therapeutics, Code C (Consultant/Contractor), Reichert,Google Inc, Heidelberg Engineering,Novartis, Code F (Financial Support), nGoogle inc, Code P (Patent), Grant: NEI EY029885, Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6473. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Veronica Campos, Carolina Gracitelli, Alessandro A Jammal, Felipe Medeiros; Estimated Rate of Retinal Ganglion Cell Loss with Aging. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6473.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the effect of aging on estimated retinal ganglion cell (RGC) counts over time in healthy eyes.

Methods : This longitudinal observational cohort study involved 100 healthy eyes of 50 subjects with an average follow-up of 3.5 ± 2.4 years. Estimated RGC counts were obtained by a previously described method using standard automated perimetry (SAP) sensitivity thresholds and optical coherence tomography (OCT) retinal nerve fiber layer thickness measurements by Medeiros et al. (Am J Ophthalmol. 2012; 154:814-824). Linear mixed-effects models were applied to investigate the relationship between age and rates of change in estimated RGC counts over time. Analyses were also performed adjusting for baseline age, OCT signal strength, and axial length.

Results : The mean age at baseline was 49.6 ± 15.7 years, ranging from 22.8 to 89.9 years. 33 (66%) patients were female and 11 (22%) self-identified as Black. At baseline, eyes had an average estimated RGC count of 1,144,010 ± 222,084 cells. Over time, the rate of change in estimated RGC count was -6,284 (95% CI: -10,804 to -1,764 RGC/year; P=0.006). After adjusting for confounding factors, the effect of time on the rate of estimated RGC loss was -6,533 RGC/year (95% CI: -11,088 to -1,979 RGC/year; P = 0.005), or an equivalent of an average loss in RGC over time of 0.5%/year.

Conclusions : Our study has demonstrated a significant age-related decline in estimated RGC counts in healthy subjects, obtained from combining information from structural and functional tests. After accounting for confounding factors, the age-related decline was comparable to those obtained in previous histologic studies reported on the literature, ranging from 0.3% and 0.6% per year. Normal aging should be considered when estimating RGC counts over time to differentiate between pathological and nonpathological losses.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×